Reducing unconscious bias in pharmacy
Part of Infections clinical trials.
This study aims to reduce unconscious bias in pharmacies by testing an intervention with pharmacy interns, managers, and policymakers in high-HIV areas of Massachusetts. If you work in a pharmacy in these areas and are willing to learn about or prescribe PrEP (HIV prevention medication), you may be eligible.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a pharmacy intern at Northeastern University doing your internship in a high-HIV area of Suffolk County, MA
- You have experience with PrEP (HIV prevention pill) or are willing to prescribe it someday
- You have a moderate to strong unconscious preference for White people (as measured by a test)
- Or you are a pharmacy manager at a pharmacy in one of those high-HIV areas
- Or you are a pharmacy policymaker (staff from the Board of Registration in Pharmacy) who works with community pharmacies
- You must be able to give consent to participate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at offering HIV prevention medicines (PrEP) to patients visiting a family planning clinic. It aims to make it easier for people to access this care alongside their regular visit.
This study tests how to better support HIV prevention for people who inject drugs and are newly starting PrEP (medicine to prevent HIV). It focuses on people taking medication for opioid use disorder and who have mild thinking and memory problems, to help them stay safe and adhere to prevention.
This study tests whether pharmacies can safely provide HIV prevention medications (PrEP for prevention, PEP for emergency treatment) and HIV testing through phone or video visits. It aims to make these services easier to access without visiting a hospital or clinic.
This study is for cis-gender men who are HIV-negative and at risk for HIV. It tests a program to help you start and stay on PrEP (medication to prevent HIV).
This study looks at ways to improve PrEP (pre-exposure prophylaxis) care by helping clinic staff track and support patients better. It's for healthcare workers, managers, and data staff at certain PrEP clinics.
This study checks whether taking HIV prevention medicine called PrEP can help protect people who are not living with HIV but have recent risk of HIV exposure. You may qualify if you have ongoing risk and are not already taking PrEP.
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.